Climb Bio, Inc. Annual Operating Income (Loss) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Climb Bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • Climb Bio, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$11.7M, a 135% decline year-over-year.
  • Climb Bio, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$76.2M, a 70.5% decline year-over-year.
  • Climb Bio, Inc. annual Operating Income (Loss) for 2023 was -$40.3M, a 10.8% increase from 2022.
  • Climb Bio, Inc. annual Operating Income (Loss) for 2022 was -$45.1M, a 26.5% decline from 2021.
  • Climb Bio, Inc. annual Operating Income (Loss) for 2021 was -$35.7M, a 70.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.